Señales en vivo de NYXH | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions...

Stats
Volumen de hoy	5 149
Volumen promedio	40 896
Capitalización de mercado	239.49M
EPS	$-0.420 ( Q1 \| 2024-03-31 )
Próxima fecha de ganancias	( $-0.450 ) 2024-08-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.33 (Sector) 42.63 (Industry) 78.56
ATR14	$0.0620 (0.89%)

GCTK 0.50%

GMVDW -1.13%

LUCY 50.00%

LUCYW 2.97%

NXGLW 0.00%

NYXH -0.57%

OMIC -9.33%

POCI 0.51%

Correlación (AI algo v.1.1b): Undervalued: 0.09% $6.98 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.23 (neutral)

Corto: 0.74 (moderate)

Signal:(46.696) Neutral

Nyxoah S.A. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nyxoah S.A. Correlación - Moneda/Commodity

0.28
( neutral )

0.24
( neutral )

0.00
( neutral )

-0.13
( neutral )

-0.12
( neutral )

-0.14
( neutral )

Nyxoah S.A. Finanzas

Annual	2023
Ingresos:	$4.35M
Beneficio Bruto:	$332 000 (7.64 %)
EPS:	$-1.550

FY	2023
Ingresos:	$4.35M
Beneficio Bruto:	$332 000 (7.64 %)
EPS:	$-1.550

FY	2022
Ingresos:	$3.08M
Beneficio Bruto:	$1.93M (62.71 %)
EPS:	$-1.210

FY	2021
Ingresos:	$852 000
Beneficio Bruto:	$549 000 (64.44 %)
EPS:	$-1.160

Financial Reports:

No articles found.

Nyxoah S.A. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nyxoah S.A.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.